Mark Fromm
Analyst
TD Cohen
Equibles does not estimate personal net worth.
About Mark Fromm
Mark Fromm is recorded as Analyst at TD Cohen. Mark Fromm has spoken on 1 earnings call across 1 company, most recently for Revolution Medicines, Inc. on February 25, 2026. The companies whose calls Mark Fromm spoke on are classified in the Healthcare sector.
Mark Fromm on recent calls
“Maybe just first off on more of a bit of a housekeeping thing, can you just confirm whether any event thresholds have been reached in 302 to trigger interim analyses yet, or if just none of those have been hit yet?”
Affiliation history
-
TD Cohen
Analyst
Transcript header (unverified)
Current